Tuftsin (Thr-Lys-Pro-Ari) receptor was purified to apparent homogeneity by affinity chromatography, using a pentapeptide analog (Thr-Lys-Pro-Pro-Arg) that binds the receptor more than 4 times as avidly as tuftsin. The analog was covalently linked to a solid support (Affi-Gel 10). Rabbit peritoneal granulocyte membrane solubilized with 3-[(3-cholamidopropyl)dimethylammonio]-l-propanesulfonate was applied to the affinity column, the column was washed with 0.1 M ammonium carbonate (pH 7.9) and 0.1 M ammonium acetate (pH 5), and bound material was eluted with 20 nM tuftsin or pentapeptide. The eluate was concentrated and subjected to gel filtration; this yielded one major peak of [3lH]tuftsin binding activity corresponding to =500 kDa and a minor peak at -250 kDa. Rechromatography of either peak resulted in the appearance of the same maor and minor peaks. NaDodSO4/PAGE of the affinity-purified material under nonreducing conditions showed only two silver-staining bands.
Tuftsin, Thr-Lys-Pro-Arg, is an immunologically active oligopeptide that is derived from the heavy chain of human immunoglobulin (residues [289] [290] [291] [292] . The release of tuftsin as the free, biologically active form is performed by two enzymes that cleave peptide bonds at each end of the tetrapeptide. One is present in the spleen, and the other, on the outer surface of the phagocytic plasma membrane (1-5). Tuftsin's chief role is to stimulate several functions of phagocytic cells, primarily in the macrophage. These functions form an important component of the immune system and comprise phagocytosis, pinocytosis, mobility (4, 5) , chemotaxis (5) (6) (7) (8) , and immunogenic activity (9) , resulting in the augmentation of the number of antibody-forming cells (10, 11) , bactericidal activity (12) , and tumoricidal activity (13) (14) (15) (16) (17) (18) . The latter has been shown in mice for L1210 cells (15) (16) (17) (18) and BCL1 leukemia cells (19) , several melanoma cell lines (16) (17) (18) , chemically induced sarcoma (14, 19) , and several virally induced tumors (20) (21) (22) .
Encouraging responses to tuftsin therapy in human neoplasia have been obtained at the Department ofOncology, Hadassah University Hospital in Jerusalem and The Weizman Institute. Of 17 patients with advanced malignancies who were getting 5 mg each i.v. twice a week, two showed remarkable responses, both clinically and radiologically: one with a nasopharyngeal tumor (14, 19) and the other with an alveolar cell carcinoma of the lung. The responses lasted 4 weeks and 10 weeks, respectively. A third patient, with chronic myeloid leukemia that had been refractory to all conventional chemotherapy, showed a definite response to tuftsin, with a precipitous reduction of the blast-cell count and the emergence of normal granulocytes. This lasted 2 weeks. Five patients remained stable for at least 1 month, while nine others showed no effect (19) .
Tuftsin also augments macrophage production of superoxide and hydrogen peroxide, over and above the increase that occurs normally during phagocytosis (23, 24) . It also increases the secretion of tumor necrosis factor (25) . Both of these effects could play a role in the destruction of cancer cells.
Seventeen human tuftsin mutants have been identified in the United States (26, 27) and two in Japan (28) . In one such patient, the mutant peptide was identified as Thr-Glu-ProArg and represents a transition mutation (A--G) where codon AAA or AAG for lysine is converted to GAA or GAG, which codes for glutamic acid (18, 29) . Such patients suffer much aggravated multiple infections (30) (31) (32) (33) (34) . In view of all these findings, tuftsin should rank as a true biological entity with a prescribed physiological role, which, when set aside, leads to physiologic impairment. This is rendered all the more compelling by the fact that only phagocytic cells, macrophages/ monocytes, and granulocytes possess specific tuftsin receptors, and only these cells respond to tuftsin activation. A study ofthe tuftsin receptor may shed light on the mechanism of its activation ofmany functions ofphagocytic cells. To that end, the isolation of the receptor becomes a necessary prerequisite for such a study. 
MATERIALS AND METHODS
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ester linkage, were cleaved by one reagent, the strong organic acid trifluoromethanesulfonic acid in anisole (36) .
Synthesis of [[3H]Arg4]Tuftsin. This was done by the classical liquid-phase method, as modified in our laboratory (37) . The principle involved is the formation of peptide bonds through the exclusive use of N-hydroxysuccinimide active ester (OSu) of suitably protected amino acid residues. NOBoc-N6-Cbz-Lys-OSu reacted with proline to yield Na-Boc-N6-Cbz-Lys-Pro-OH. N-Boc was removed by trifluoroacetic acid, and the dipeptide was treated with Na-Boc-O-Bzl-
The free carboxyl group of the tripeptide was then esterified with N-hydroxysuccinimide by the action of dicyclohexylcarbodiimide. The activated tripeptide was then allowed to react with [3H]arginine in dioxane/aqueous bicarbonate (1:1) at pH 8.4. Under these conditions, the yield does not exceed 40%. An anomalous reaction takes place (38) . The nucleophilic a-amino function of arginine attacks the carbonyl nitrogen bond of the strained succinimidyl ring instead of the ester carbonyl function of proline. The result is opening of the succinimidyl ring and the covalent incorporation of the linearized moiety between the arginine and proline residues. This compound gives a blue color on thin layer chromatograms when sprayed with ninhydrin.
Precipitation of Receptor by PEG. Casein and lysozyme (1 mg each) were added to aliquots of solubilized receptor, followed by the addition of PEG 6000 to a concentration of 13% (wt/vol). The precipitate was glass-filtered (Whatman) and then washed with 15% PEG.
RESULTS
Our main objective is the characterization of the tuftsin receptor that is present in the plasma membrane of neutrophilic granulocytes. Purification of the receptor to apparent homogeneity is necessary before its characteristics and possible subunit structure can be investigated.
Purification on Affinity Columns. Unless otherwise indicated, all buffers and solutions used in the purification (from isolated cells to the final steps) contained 8 mM CHAPS, protease inhibitors [phenylmethylsulfonyl fluoride (2 mM), aprotinin (0.5 trypsin inhibitor unit/ml), pepstatin (2.5 ,ug/ml), antipain (1 ,ug/ml), and leupeptin (20 ,uM)], and 0.02% sodium azide.
Peritoneal rabbit neutrophils were induced by 0.25% glycogen in 0.9% NaCl, harvested, and washed with 0.9% NaCl. Aliquots (2 x 109 cells) were suspended in 5 ml of 0.37 M sucrose/5 mM phosphate, pH 7.4, and left overnight at 4°C (39). They were then homogenized (20 strokes at 0°C with a glass/Teflon tight-fitting homogenizer) and centrifuged at 300 x g for 15 min. The supernatant, containing cell membranes, was centrifuged at 15,000 x g for 30 min. The pellet was suspended in 1 ml of 8 mM CHAPS and centrifuged at 30,000 x g for 30 min. The clear supernatant was passed through the affinity gel-pentapeptide column at a rate of 10 ml/hr.
The columns were prepared as follows: Affi-Gel 10 (25 ml), activated as N-hydroxysuccinimide ester, was treated with 25 mg of the pentapeptide analog (Thr-Lys-Pro-Pro-Arg). The latter binds the receptor about 4 times more avidly than tuftsin (40) . The reaction was carried out in 0.1 M Hepes (pH 7.9) in a final volume of 25 ml for 24 hr at 4°C. Any remaining kDa; aldolase, 158 kDa; and ovalbumin, 43 kDa). Affinity-purified tuftsin receptor (-1.0 ,ug) was loaded on the column and chromatographed at 10 ml/hr; 2-ml fractions were collected. To aliquots (0.9 ml each), 25 pmol of [3H]tuftsin was added. Another 0.9-ml aliquot of each sample had in addition 25 nmol of nonradioactive tuftsin as competitor. All samples were incubated at 0°C for 30 min. Lysozyme and casein were then added as carrier, and proteins were precipitated with PEG. The precipitates were washed with PEG solution and radioactivity was measured by liquid scintillation counting. For control blank (no receptor) incubations, radioactivity was 200-230 cpm. Consequently, 215 cpm has been subtracted from the values plotted. Precipitated radioactivity in samples to which nonlabeled tuftsin was added as competitor was similar to that of the control blank. Protein concentration was estimated as follows. In a parallel run, 12 mg of protein representing 2 x 109 cells were affinity-purified. The eluted receptor (20 ml) was concentrated, subjected to NaDodSO4/PAGE, and stained with silver using bovine serum albumin as standard. assess the purity of the preparation. The receptor that was applied to the gel was not reduced, alkylated, or boiled. Such treatment destroys the binding capacity of the receptor (39) . The affinity-purified receptor showed two silver-stained bands (Fig. 2) . Both the 500-kDa and 250-kDa species obtained by gel filtration showed the same two bands with the same mobility (data not shown).
Electrophoretic transfer from gels to nitrocellulose membranes at pH 8.3 was carried out according to Towbin et al. (45) . The nitrocellulose blot was then overlaid with [3H]tuftsin. Fluorography revealed two adjacent radioactive bands that corresponded in mobility to the silver-stained bands (Fig.  2) .
To determine the subunit composition and size of the receptor, samples (and standards) were sequentially denatured with urea, reduced with dithiothreitol in 2.5% NaDodSO4, alkylated with iodoacetamide, subjected to concentration dialysis, and boiled in Laemmli (43) sample buffer. Under these conditions, the receptor loses its capacity to bind tuftsin. In fact, mere thiol treatment of the cell-bound receptor greatly diminishes its specific binding (39) . Estimates of molecular mass were done on 20 receptor preparations. All showed only two bands, at 62 kDa and 52 kDa (a and 8 subunit, respectively). Treatment with endoglycosidase H did not alter the mobility (Fig. 3) .
Electron Microscopy. This revealed a population of uniform spherical molecules with little if any contaminant (Fig. 4) .
The molecule has a diameter of 104 A. On (Fig. 1) . Little or no binding occurred with fractions corresponding to the molecular masses of the two subunits. NaDodSO4/PAGE of the nonreduced receptor showed only two silver-stained bands. These corresponded to the only two
[3H]tuftsin-binding bands detected (Fig. 2 ).
It appears that the receptor has been resolved into an a and a p subunit. Apparent molecular masses of 62 kDa and 52 kDa, respectively, were derived from the mobility of the reduced, alkylated, and boiled receptor in NaDodSO4/ PAGE. Treatment of the receptor with endoglycosidase H did not influence the mobility of the subunits (Fig. 3) .
Despite the very low concentration of the receptor, the presence of a predominant 500-kDa species, as obtained by gel filtration, indicates that the dissociation of the individual subunits must be very low indeed. Assuming that the 500-kDa oligomer is composed of equal numbers of a and 8 subunits, we suggest that the receptor is an a4,84 octamer.
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